Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
July 31, 2025PharmaceuticsOpen Access

Leveraging the Tumor Microenvironment as a Target for Cancer Therapeutics: A Review of Emerging Opportunities

View Full Paper
Ask AI
Bookmark
Share

Authors

HGHakan GüvenZSZoltán Székely

Discussion

Loading...

Member takes

Overview

Review highlights how tumor microenvironment influences cancer therapeutics, suggesting novel strategies for targeting specific parameters.

Key Points

  • MAIN FINDING: The tumor microenvironment presents unique challenges and opportunities for cancer therapeutics.
  • KEY EVIDENCE: Significant changes occur in the microenvironment as tumors exceed 1–2 mm3, impacting treatment efficacy.
  • APPROACH: The review examines five key parameters of the tumor microenvironment and their relevance to cancer types.
  • SIGNIFICANCE: Understanding TME dynamics can lead to more effective therapeutic designs and improved cancer treatment outcomes.

Cite This Study

Güven et al. (2025) studied this question.

synapsesocial.com/papers/689a094be6551bb0af8cf3e6https://doi.org/10.3390/pharmaceutics17080980
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Antibody drug conjugate: the “biological missile” for targeted cancer therapy2022 · 1,630 citations
  2. 2Trastuzumab Emtansine for HER2-Positive Advanced Breast Cancer2012 · 3,839 citations
  3. 3Antibody-Drug Conjugates in Solid Tumor Oncology: An Effectiveness Payday with a Targeted Payload2023 · 46 citations
  4. 4The role of tumor microenvironment in drug resistance: emerging technologies to unravel breast cancer heterogeneity2023 · 79 citations
  5. 5NADPH:cytochrome c (P450) reductase activates tirapazamine (SR4233) to restore hypoxic and oxic cytotoxicity in an aerobic resistant derivative of the A549 lung cancer cell line2000 · 51 citations